Rare diseases
Investigational molecules
Locations
Back to Portugal51 clinical trials in Santa Maria Da Feira, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)PortugalStudy on the Long-term Safety and Tolerability of Azetukalner for Patients with Epilepsy, Including Focal-onset and Primary Generalized Tonic-Clonic Seizures
PortugalStudy on the Effects of Azetukalner in Patients with Focal-Onset Seizures
PortugalStudy on the Effects of XEN1101 and Placebo for Patients with Primary Generalized Tonic-Clonic Seizures
PortugalSARS‑CoV‑2 spike protein vaccine and drug combination study in adults 60 years and older with COVID‑19 and influenza
PortugalPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
PortugalStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
PortugalStroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)
PortugalA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
PortugalA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
PortugalStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
PortugalStudy of ISIS 678354 for Patients with Severe High Triglycerides
PortugalThe busiest research cities in the country
What the registry says about research in the country
Ongoing research evaluating novel treatments for multiple sclerosis and epilepsy, with studies focusing on both relapsing and progressive forms of MS, as well as various types of seizure disorders.
Multiple trials testing new compounds like tolebrutinib and fenebrutinib for long-term disease management.
Studies focusing on preventing cardiovascular events and managing atherosclerotic disease, with particular attention to high-risk patients and post-stroke care.
Innovative therapies being tested to reduce major adverse cardiovascular events and improve patient outcomes.
Research targeting inflammatory bowel diseases, including studies on Crohn's Disease and ulcerative colitis, testing new therapeutic approaches.
Evaluating combination therapies and novel compounds for moderate to severe disease states.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
